• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 期刊论文
  5. High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with line

High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with line

来源 :国际肝胆胰疾病杂志：英文版 | 被引量 : 0次 | 上传用户：bbanb
【摘 要】
：
BACKGROUND:Linezolid is an effective antibiotic reagent for Gram-positive bacterial infection;its most common side effect is thrombocytopenia.However,the incide
【作 者】
：
Zhang  Yi-Min Yu  Wei Zhou  Ni 
【机 构】
：
ZhejiangUniv,CollaboratInnovatCtrDiag&,TreatmentInfectDi
【出 处】
：
国际肝胆胰疾病杂志：英文版
【发表日期】
：
2015年3期
【关键词】
：
血小板减少 治疗 衰竭 急性 高频率 胺 革兰氏阳性菌 ACLF acute-on-chronic liver failure  linezolid  thro 
【基金项目】
：
supported by grants from the China National Science and Technology Major Project(2012ZX10002004 and 2013ZX10002001),Zhejiang CTM Science and Technology Project(2011ZB061)
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND:Linezolid is an effective antibiotic reagent for Gram-positive bacterial infection;its most common side effect is thrombocytopenia.However,the incidence of thrombocytopenia in patients with acute-on-chronic liver failure(ACLF)who underwent line
其他文献
Esophagogastric devascularization without splenectomy in portal hypertension： safe and effective？
BACKGROUND: Esophagogastric variceal hemorrhage is a life-threatening complication of portal hypertension. In this study, we compared the therapeutic effect of
期刊
断流高压安全脾治疗效果静脉曲张门静脉并发症portal hypertension esophagogastric devascularizat
Effects of Kupffer cell inactivation on graft survival and liver regeneration after partial liver tr
BACKGROUND: Gadolinium chloride(Gd Cl3) selectively inactivates Kupffer cells and protects against ischemia/reperfusion and endotoxin injury. However, the effec
期刊
枯否细胞肝移植肝再生存活率失活大鼠WESTERN印迹天冬氨酸转氨酶GdCI3Kupffer cellspartial liver trans
Impact of centralization of pancreaticoduodenec-tomy coupled with fast track recovery protocol:a com
BACKGROUND: Fast track strategy in the management of patients undergoing intra-abdominal surgery of various types has emerged as a landmark approach to reduce s
期刊
Surgical treatment of synchronous colorectal liver and lung metastases： the usefulness of thoracophr
When suitable, surgery still remains the therapeutic option to be preferred for patients carrier of colorectal liver and lung metastases. Since thoracophrenolap
期刊
结肠直肠肝脏肺切除colorectal carcinoma liver metastases lung metastases thoracophren
Clinical factors affecting rejection rates in liver transplantation
BACKGROUND: With improvements in survival, liver transplant recipients now suffer more morbidity from long-term immunosuppression. Considerations were given to
期刊
排斥反应肝移植白细胞介素-2临床发生率慢性乙型肝炎受体拮抗剂肝功能衰竭liver transplantation acute rejectio
Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
<正>BACKGROUND:Prothymosinα(PTMA)is a nuclear oncoprotein-transcription factor essential for cell cycle progression and proliferation.PTMA was overexpressed in
期刊
预测性胸腺素肝癌复发早期预后恶性肿瘤蛋白表达prothymosin a hepatocellular carcinoma recurrence
Liver resection for the treatment of a congenita ntrahepatic portosystemic venous shunt
Intrahepatic portosystemic shunts(IPSS) are rare congenital anomalies arising from disordered portal vein embryogenesis.It has been described in both children a
期刊
治疗方案先天性切除术门静脉分流门体肝外科手术intrahepatic portosystemic shuntliver resection
Conversion of twice-daily to once-daily tacro- limus is safe in stable adult living donor liver tran
BACKGROUND: Once-daily extended-release tacrolimus(Tac-OD) has been introduced as a useful therapeutic option to increase patient adherence to immunosuppressive
期刊
安全稳定肝移植活体成人TAC排斥反应安全有效性免疫抑制liver transplantation living donor immunosu
Letters to the Editor
<正>The Editor welcomes submissions for possible publication in the Letters to the Editor section.Letters commenting on an article published in the Journal or o
期刊
编辑部出版物信件作者welcomes matching pieces obesity alcohol letter rendering adjustme
Everolimus in de novo liver transplant recipients： a systematic review
BACKGROUND: Everolimus has no nephrotoxicity and is used to treat patients with post-liver transplant chronic renal insufficiency. The present systematic review
期刊
肝移植系统随机对照试验肾功能不全CNIs可信区间META分析肾小球滤过率everolimus calcineurin inhibitors li